Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Oncotargets and Therapy|August 1, 2015
Volasertib for AML: clinical use and patient considerationZhonglin Hao, Vamsi KotaClinical Lymphoma, Myeloma & Leukemia|June 8, 2019
Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Tyrosine Kinase Inhibitor Therapy CessationVamsi Kota, Ehab AtallahFuture Oncology (London, England)|October 28, 2016
Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemiaElliott F Winton, Vamsi KotaJournal of Investigative Medicine High Impact Case Reports|November 17, 2016
Recurrent Parotid Carcinosarcoma in an Asymptomatic PatientJoshua Mansour, Abhishek Mangaonkar, Vamsi KotaFrontiers in Oncology|July 16, 2024
Exploring treatment decision-making in chronic myeloid leukemia in chronic phaseDavid Andorsky, Vamsi Kota, Kendra SweetSchizophrenia Bulletin|June 4, 2026
Clozapine-Induced "Pseudo-Agranulocytosis": Bone Marrow Suppression or Increased Neutrophil Margination?Brian J Miller, Nabil Ghani, Vamsi KotaAmerican Journal of Translational Research|October 12, 2020
Age and race distribution in patients in phase III oncology clinical trialsSwathi Gopishetty, Vamsi Kota, Achuta K GuddatiCase Reports in Oncological Medicine|April 23, 2020
Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHDPhilip T Sobash, Achuta K Guddati, Vamsi KotaCase Reports in Oncology|June 11, 2020
Management of a 75-Year-Old Lady with Refractory Chronic Myelogenous LeukemiaPhilip T Sobash, Achuta K Guddati, Vamsi KotaJournal of Investigative Medicine High Impact Case Reports|August 20, 2019
Rectovaginal Fistula as a Complication of Fecal Management SystemEmily Butts, Sandeep Anand Padala, Anusha Vakiti, et al.Pageof 9